HIV: open trials in Netherlands

14 open trials have a site in Netherlands. Registry data; only the trial team decides who can take part.

2025-524336-19-00
Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens
Trial Treatment · Phase 3 · Gilead Sciences Inc.
Amsterdam UMC Stichting, Amsterdam · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam
Registry updated 2026-10-06
2025-524335-39-00
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
Trial Treatment · Phase 3 · Gilead Sciences Inc.
Leids Universitair Medisch Centrum (LUMC), Leiden · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-07-27
NCT07636928
Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184
Trial Treatment · Phase 1 · ViiV Healthcare
Groningen
Registry updated 2026-07-02
NCT06900829
#AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-implementation Trial.
Trial Treatment · Casper Rokx
Rijnstate Ziekenhuis, Arnhem · Stichting Catharina Ziekenhuis, Eindhoven · University Medical Center Groningen, Groningen · Stichting Maasstad Ziekenhuis, Rotterdam · Haga Ziekenhuis, The Hague
Registry updated 2026-03-12
NCT07384624
Combining Latency Reversing Agents to Address the HIV Reservoir
Trial Treatment · Phase 1/2 · Erasmus Medical Center
Amsterdam UMC Stichting, Amsterdam · Radboud universitair medisch centrum Stichting, Nijmegen · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2026-02-03
NCT06282783
Research into topiramate to remove the hidden HIV in people living with HIV taking HIV treatment
Trial Treatment · Phase 2 · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam
Registry updated 2025-10-13
2023-510354-16-00
The impact of vaccine platform, age and HIV infection on germinal centre formation.
Trial Treatment · Phase 4 · Academisch Ziekenhuis Leiden
Leids Universitair Medisch Centrum (LUMC), Leiden
Registry updated 2025-01-31
NCT00825929
Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.
Research · Phase 4 · Radboud University Medical Center
Amsterdam UMC Stichting, Amsterdam · Universitair Medisch Centrum Groningen, Groningen · Radboud universitair medisch centrum Stichting, Nijmegen · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Stichting Elisabeth-TweeSteden Ziekenhuis, Tilburg · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2025-01-13
NCT06706986
A Global Registry On Second gEneration and Long-acting inTegrase inhibiTor fAilures
Research · UMC Utrecht
University Medical Center Utrecht, Utrecht
Registry updated 2024-11-27
NCT04319367
A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).
Trial Treatment · Phase 2 · Imperial College London
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam
Registry updated 2024-04-17
NCT02699736
EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV
Research · Copenhagen University Hospital, Rigshospitalet
Academisch Ziekenhuis bij de Universiteit van Amsterdam, Amsterdam
Registry updated 2024-04-12
NCT05215704
Ex Vivo Characterization and Targeting of the Latent HIV Infected Reservoir to Cure HIV
Research · Erasmus Medical Center
Erasmus Medical Centre, Rotterdam
Registry updated 2024-02-14
NCT05231135
A Registry Study on HIV-related Lymphoma
Research · Rotkreuzklinikum München gGmbH
Amsterdam University Medical Centers, Amsterdam
Registry updated 2023-04-06
NCT05728996
Netherlands Cohort Study on Acute HIV Infection
Research · Prof. Jan Prins
Amsterdam UMC, location AMC, Amsterdam
Registry updated 2023-02-15

All HIV trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error